Skip to main content
SpringerLink
Log in
Book cover

Nonmalignant Hematology pp 485–494Cite as

Antiphospholipid Antibodies and Syndrome: Complexities in Diagnosis and Management

  • Chapter
  • First Online:

  • 1607 Accesses

Abstract

Antiphospholipid syndrome (APS) is characterised by arterial and/or venous thromboses and/or obstetric morbidity (obstetric APS) in patients persistently positive for antiphospholipid antibodies (aPL). The classification criteria for APS have been defined in the original Sapporo criteria, which more recently have been updated in the Sydney criteria (ss) (Miyakis et al. 2006).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • [CG144], N.g., Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. NICE guidelines, 2012. https://www.nice.org.uk/guidance/cg144/chapter/recommendations

  • Banzato A, et al. Antibodies to Domain I of beta(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS). Thromb Res. 2011;128(6):583–6.

    Article  CAS  PubMed  Google Scholar 

  • Bramham K, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus. 2010;19(1):58–64.

    Article  CAS  PubMed  Google Scholar 

  • Bramham K, et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood. 2011;117(25):6948–51.

    Article  CAS  PubMed  Google Scholar 

  • Bouvier et al. Blood 2013;123(3):414–421.

    Google Scholar 

  • Cabral AR, et al. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Am J Med. 1996;101(5):472–81.

    Article  CAS  PubMed  Google Scholar 

  • Cervera R, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2015;74(6):1011–8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24.

  • Crowther et al. N Engl J Med 2003;349:1133–8.

    Google Scholar 

  • Danza et al. Antiphospohlipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):65–76. doi: 10.1016/j.bpobgyn.2011.10.006. Epub 2011 Nov 11.

  • Dendrinos S, Sakkas E, Makrakis E. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome. Int J Gynaecol Obstet. 2009;104(3):223–5.

    Google Scholar 

  • Erkan D, et al. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford). 2002;41(8):924–9.

    Article  CAS  Google Scholar 

  • Erkan D, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56(7):2382–91.

    Article  CAS  PubMed  Google Scholar 

  • Erkan D, et al. 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends. Autoimmun Rev. 2014;13(6):685–96.

    Google Scholar 

  • Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002;100(3):408–13.

    CAS  PubMed  Google Scholar 

  • Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368(11):1033–44.

    Article  CAS  PubMed  Google Scholar 

  • Giannakopoulos B, et al. How we diagnose the antiphospholipid syndrome. Blood. 2009;113(5):985–94.

    Article  CAS  PubMed  Google Scholar 

  • Jeleniewicz R, et al. Prevalence of antiphospholipid antibodies in rheumatoid arthritis patients and relationship with disease activity. Pol Arch Med Wewn. 2012;122(10):480–6.

    CAS  PubMed  Google Scholar 

  • Keeling D, et al. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157(1):47–58.

    Article  CAS  PubMed  Google Scholar 

  • Khamashta MA, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med. 1995;332(15):993–7.

    Article  CAS  PubMed  Google Scholar 

  • Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174(5):1584–9.

    Article  CAS  PubMed  Google Scholar 

  • Lakasing L, Khamashta M. Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: what advice should we be giving? J Fam Plann Reprod Health Care. 2001;27(1):7–12.

    Article  CAS  PubMed  Google Scholar 

  • Laskin CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol. 2009;36(2):279–87.

    Article  CAS  PubMed  Google Scholar 

  • Matsuura E, et al. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 1994;179(2):457–62.

    Article  CAS  PubMed  Google Scholar 

  • Miyakis S, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

    Article  CAS  PubMed  Google Scholar 

  • Mok CC, et al. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum. 2005;52(9):2774–82.

    Article  PubMed  Google Scholar 

  • Otomo K, et al. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012;64(2):504–12.

    Article  CAS  PubMed  Google Scholar 

  • Parmar K, et al. The utility of the Taipan snake venom assay in assessing lupus anticoagulant status in individuals receiving or not receiving an oral vitamin K antagonist. Blood Coagul Fibrinolysis. 2009; 20(4):271–5.

    Article  CAS  PubMed  Google Scholar 

  • Pengo V, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7(10):1737–40.

    Article  CAS  PubMed  Google Scholar 

  • Pengo V, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood. 2011;118(17):4714–8.

    Article  CAS  PubMed  Google Scholar 

  • Rai R, et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314(7076):253–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992;117(4):303–8.

    Article  CAS  PubMed  Google Scholar 

  • Ruiz-Irastorza G, et al. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498–509.

    Article  CAS  PubMed  Google Scholar 

  • Sciascia S. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism. Blood Coagul Fibrinolysis. 2015;26(4):476–7. doi: 10.1097/MBC.0000000000000247.

  • Sciascia S, Bertolaccini ML. Thrombotic risk assessment in APS: the Global APS Score (GAPSS). Lupus. 2014;23(12):1286–7.

    Article  CAS  PubMed  Google Scholar 

  • Sciascia S, et al. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost. 2012;10(12):2512–8.

    Article  CAS  PubMed  Google Scholar 

  • Sciascia S, et al. GAPSS: the Global Anti-Phospholipid Syndrome Score. Rheumatology (Oxford). 2013;52(8):1397–403.

    Article  Google Scholar 

  • Sneddon IB. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol. 1965;77:180–5.

    Article  CAS  PubMed  Google Scholar 

  • Tektonidou MG, et al. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum. 2009;61(1):29–36.

    Article  PubMed  Google Scholar 

  • Tincani A, et al. Overview on anticardiolipin ELISA standardization. J Autoimmun. 2000;15(2):195–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thrombosis and Haemostasis, Guys and St Thomas’ NHS Foundation Trust, London, SE1 7EH, UK

    Karen Schreiber & Beverley J. Hunt

  2. Department of Rheumatology, Copenhagen University Hospital at Rigshospitalet, Copenhagen, Denmark

    Karen Schreiber

  3. Thrombosis & Thrombophilia, Guy’s & St Thomas’ Hospital, London, SE1 7EH, UK

    Savino Sciascia

  4. Department of Clinical and Biological Sciences, Center of Research of Immunopathology and Rare Diseases- Coordinating Center of the Network for Rare Diseases of Piedmont and Aosta Valley, University of Turin, Turin, Italy

    Savino Sciascia

  5. Thrombosis & Haemostasis, Kings College University, London, UK

    Beverley J. Hunt

Authors
  1. Karen Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Savino Sciascia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beverley J. Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beverley J. Hunt .

Editor information

Editors and Affiliations

  1. Cancer Treatment Centers of America, Department of Hematology and Bone Marrow Transplantion, Zion, Illinois, USA

    Syed A. Abutalib

  2. Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, USA

    Jean M. Connors

  3. Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Margaret V. Ragni

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Schreiber, K., Sciascia, S., Hunt, B.J. (2016). Antiphospholipid Antibodies and Syndrome: Complexities in Diagnosis and Management. In: Abutalib, S., Connors, J., Ragni, M. (eds) Nonmalignant Hematology. Springer, Cham. https://doi.org/10.1007/978-3-319-30352-9_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30352-9_42

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30350-5

  • Online ISBN: 978-3-319-30352-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation